These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16628418)

  • 1. Estimation of visual outcome without treatment in patients with subfoveal choroidal neovascularization in pathologic myopia.
    Kojima A; Ohno-Matsui K; Teramukai S; Ishihara Y; Shimada N; Yoshida T; Sugamoto Y; Tokoro T; Mochizuki M
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1474-9. PubMed ID: 16628418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab.
    Yang HS; Kim JG; Kim JT; Joe SG
    Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Ng DS; Kwok AK; Tong JM; Chan CW; Li WW
    Retina; 2015 Dec; 35(12):2457-68. PubMed ID: 26035400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.
    Costagliola C; Campa C; Incorvaia C; Parmeggiani F; Menzione M; Della Corte M; Rinaldi M; Romano M; Semeraro F
    Eur J Ophthalmol; 2008; 18(6):955-9. PubMed ID: 18988168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy.
    Maár N; Ergun E; Luksch A; Stur M
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1262-6. PubMed ID: 16538450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
    Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy in subfoveal and juxtafoveal myopic choroidal neovascularization: a 10-year retrospective analysis.
    Varano M; Iacono P; Giorno P; Chiaravalloti A; Parravano M
    Ophthalmologica; 2014; 231(4):204-10. PubMed ID: 24481122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIX-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA.
    Kasahara K; Moriyama M; Morohoshi K; Yoshida T; Simada N; Nagaoka N; Yokoi T; Shinohara K; Kaneko Y; Suga M; Ohno-Matsui K
    Retina; 2017 Jun; 37(6):1055-1064. PubMed ID: 27755380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of prognostic factors for choroidal neovascularization due to pathological myopia treated by intravitreal bevacizumab injection.
    Wang J; Kang Z
    Graefes Arch Clin Exp Ophthalmol; 2012 Dec; 250(12):1717-23. PubMed ID: 23007232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of photodynamic therapy for choroidal neovascularization in Japanese patients with pathologic myopia.
    Hayashi K; Ohno-Matsui K; Shimada N; Moriyama M; Hayashi W; Wang J; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2011 Jan; 151(1):137-147.e1. PubMed ID: 20970774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hayashi W; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choroidal thickness after treatment for myopic 
choroidal neovascularization.
    Farinha CL; Baltar AS; Nunes SG; Franqueira NF; Figueira JP; Pires IA; Cachulo ML; Silva RM
    Eur J Ophthalmol; 2013; 23(6):887-98. PubMed ID: 23787449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.
    Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ
    Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study.
    Bruè C; Pazzaglia A; Mariotti C; Reibaldi M; Giovannini A
    Eye (Lond); 2016 Jan; 30(1):139-45. PubMed ID: 26514244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of patients with a favorable natural course of myopic choroidal neovascularization.
    Hayashi K; Ohno-Matsui K; Yoshida T; Kobayashi K; Kojima A; Shimada N; Yasuzumi K; Futagami S; Tokoro T; Mochizuki M
    Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):13-9. PubMed ID: 15290153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization.
    Ahn SJ; Park KH; Woo SJ
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of subfoveal neovascularization in myopia: macular translocation vs surgical removal.
    Hamelin N; Glacet-Bernard A; Brindeau C; Mimoun G; Coscas G; Soubrane G
    Am J Ophthalmol; 2002 Apr; 133(4):530-6. PubMed ID: 11931787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term variable outcome of myopic choroidal neovascularization treated with ranibizumab.
    Cohen SY; Nghiem-Buffet S; Grenet T; Dubois L; Ayrault S; Fajnkuchen F; Delahaye-Mazza C; Quentel G; Tadayoni R
    Jpn J Ophthalmol; 2015 Jan; 59(1):36-42. PubMed ID: 25416566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of periconus choroidal neovascularization in pathologic myopia.
    Nagaoka N; Shimada N; Hayashi W; Hayashi K; Moriyama M; Yoshida T; Tokoro T; Ohno-Matsui K
    Am J Ophthalmol; 2011 Sep; 152(3):420-427.e1. PubMed ID: 21696698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A; Isola V; Vadalà M; Matranga D
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.